British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing. The funds are set to be spread ...

While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways with more than 100 staffers at a Massachusetts facility that will pivot to ...

GlaxoSmithKline is temporarily halting nationwide production of some of its Excedrin products, ABC affiliate WSYR reported. The drugmaker is halting production of Excedrin Extra Strength and Excedrin ...

Samsung Biologics will acquire a drug manufacturing facility in the United States from GlaxoSmithKline (GSK) for $280 million, marking its first production foothold in the country as it seeks to ...

GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...

SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics said on Monday its U.S. unit is buying a U.S. drug production facility from GSK for $280 million. Samsung Biologics America is acquiring a 100 ...